Jean‐Antoine Pournaras

Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization

Lazaros Konstantinidis, Irmela Mantel, Jean‐Antoine Pournaras et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2008 · 70 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +14

Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection

Alejandra Daruich, Quentin Le Rouzic, Laurent Jonet et al. · Science Advances · 2019 · 60 citations · Full text

Medicine, Neuroscience, Ophthalmology +17

Reduction of choroidal neovascularization in mice by adeno‐associated virus‐delivered anti‐vascular endothelial growth factor short hairpin RNA

Anne Louise Askou, Jean‐Antoine Pournaras, Maria Pihlmann Kristensen et al. · The Journal of Gene Medicine · 2012 · 55 citations

Medicine, Ophthalmology, Vision Science +17

Intravitreal ranibizumab (Lucentis®) in the treatment of retinal angiomatous proliferation (RAP)

Lazaros Konstantinidis, Evangelia Mameletzi, Irmela Mantel et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2009 · 55 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +10

Ultrasound assessment of short‐term ocular vascular effects of intravitreal injection of bevacizumab (Avastin^®) in neovascular age‐related macular degeneration

Philippe Bonnin, Jean‐Antoine Pournaras, Z. Lazrak et al. · Acta Ophthalmologica · 2009 · 53 citations

Health Professions, Ophthalmology, Pharmacotherapy +17